{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:53:58Z","timestamp":1794106438229,"version":"4.8.0"},"reference-count":120,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Despite innovative advances in anti-infective therapies and vaccine development technologies, community-acquired pneumonia (CAP) remains the most persistent cause of infection-related mortality globally. Confronting the ongoing threat posed by Streptococcus pneumoniae (the pneumococcus), the most common bacterial cause of CAP, particularly to the non-immune elderly, remains challenging due to the propensity of the elderly to develop invasive pneumococcal disease (IPD), together with the predilection of the pathogen for the heart. The resultant development of often fatal cardiovascular events (CVEs), particularly during the first seven days of acute infection, is now recognized as a relatively common complication of IPD. The current review represents an update on the prevalence and types of CVEs associated with acute bacterial CAP, particularly IPD. In addition, it is focused on recent insights into the involvement of the pneumococcal pore-forming toxin, pneumolysin (Ply), in subverting host immune defenses, particularly the protective functions of the alveolar macrophage during early-stage disease. This, in turn, enables extra-pulmonary dissemination of the pathogen, leading to cardiac invasion, cardiotoxicity and myocardial dysfunction. The review concludes with an overview of the current status of macrolide antibiotics in the treatment of bacterial CAP in general, as well as severe pneumococcal CAP, including a consideration of the mechanisms by which these agents inhibit the production of Ply by macrolide-resistant strains of the pathogen.<\/jats:p>","DOI":"10.3390\/ijms241311038","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T01:32:18Z","timestamp":1688434338000},"page":"11038","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5925-6452","authenticated-orcid":false,"given":"Ronald","family":"Anderson","sequence":"first","affiliation":[{"name":"Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria 0001, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand Medical School, 7 York Road, Johannesburg 2193, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s12325-020-01248-7","article-title":"Burden of community-acquired pneumonia and unmet clinical needs","volume":"37","author":"Sarda","year":"2020","journal-title":"Adv. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/cid\/cix549","article-title":"Evolving understanding of the causes of pneumonia in adults, with special attention to the role of pneumococcus","volume":"65","author":"Musher","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41479-020-00074-3","article-title":"Etiology of community-acquired pneumonia in adults: A systematic review","volume":"12","author":"Shoar","year":"2020","journal-title":"Pneumonia"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ijid.2004.07.013","article-title":"Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults","volume":"9","author":"Korsgaard","year":"2005","journal-title":"Int. J. Infect. Dis."},{"key":"ref_5","unstructured":"GBD 2016 Lower Respiratory Infections Collaborators (2018). Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect. Dis., 18, 1191\u20131210."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/S2589-7500(21)00077-7","article-title":"Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: A prospective analysis of surveillance data","volume":"3","author":"Brueggemann","year":"2021","journal-title":"Lancet Digit. Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/cid\/ciab382","article-title":"Substantial decline in invasive pneumococcal disease during coronavirus disease 2019 pandemic in Hong Kong","volume":"74","author":"Teng","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/cid\/ciac100","article-title":"Re-emergence of invasive pneumococcal disease in Germany during the spring and summer of 2021","volume":"75","author":"Perniciaro","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.111.040766","article-title":"Cardiac complications in patients with community-acquired pneumonia incidence, timing, risk factors, and association with short-term mortality","volume":"125","author":"Musher","year":"2012","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Tralh\u00e3o, A., and P\u00f3voa, P. (2020). Cardiovascular events after community-acquired pneumonia: A global perspective with systematic review and meta-analysis of observational studies. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020414"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Pieralli, F., Vannucchi, V., Nozzoli, C., Augello, G., Dentali, F., De Marzi, G., Uomo, G., Risaliti, F., Morbidoni, L., and Mazzone, A. (2021). Acute cardiovascular events in patients with community acquired pneumonia: Results from the observational prospective FADOI-ICECAP study. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-05891-5"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/518849","article-title":"The association between pneumococcal pneumonia and acute cardiac events","volume":"45","author":"Musher","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","first-page":"A4230","article-title":"Cardiovascular events and 1-year mortality in pneumococcal community-acquired pneumonia (CAP) compared to non-pneumococcal CAP","volume":"199","author":"Saikumar","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_14","first-page":"OA3306","article-title":"Bacteremic pneumococcal pneumonia is associated with an increased rate of cardiovascular events","volume":"54","author":"Borsa","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"ofaa522","DOI":"10.1093\/ofid\/ofaa522","article-title":"Host- and pathogen-related factors for acute cardiac events in pneumococcal pneumonia","volume":"7","author":"Rombauts","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e059713","DOI":"10.1136\/bmjopen-2021-059713","article-title":"Risk of cardiovascular events leading to hospitalisation after Streptococcus pneumoniae infection: A retrospective cohort LIFE study","volume":"12","author":"Nishimura","year":"2022","journal-title":"BMJ Open"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.arbr.2020.07.003","article-title":"Early and late cardiovascular events in patients hospitalized for community-acquired pneumonia","volume":"56","author":"Almirall","year":"2020","journal-title":"Arch. Bronconeumol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41479-023-00110-y","article-title":"Acute organ injury and long-term sequelae of severe pneumococcal infections","volume":"15","author":"Kruchow","year":"2023","journal-title":"Pneumonia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1093\/cid\/ciaa1427","article-title":"Major adverse cardiovascular events during invasive pneumococcal disease are serotype dependent","volume":"72","author":"Africano","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/joim.12875","article-title":"Pathogenesis and prevention of risk of cardiovascular events in patients with pneumococcal community-acquired pneumonia","volume":"285","author":"Feldman","year":"2019","journal-title":"J. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000493572","article-title":"Beneficial effects of vaccination on cardiovascular events: Myocardial infarction, stroke, heart failure","volume":"141","author":"Fountoulaki","year":"2018","journal-title":"Cardiology"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Jaiswal, V., Ang, S.P., Lnu, K., Ishak, A., Pokhrel, N.B., Chia, J.E., Hajra, A., Biswas, M., Matetic, A., and Dhatt, R. (2022). Effect of pneumococcal vaccine on mortality and cardiovascular outcomes: A systematic review and meta-analysis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11133799"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1172\/JCI39843","article-title":"Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease","volume":"120","author":"Rosch","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1182\/asheducation-2017.1.423","article-title":"Cardiovascular complications in patients with sickle cell disease","volume":"2017","author":"Gladwin","year":"2017","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Anderson, R., Nel, J.G., and Feldman, C. (2018). Multifaceted role of pneumolysin in the pathogenesis of myocardial injury in community-acquired pneumonia. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19041147"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12931-018-0777-0","article-title":"Human alveolar macrophages predominately express combined classical M1 and M2 surface markers in steady state","volume":"19","author":"Mitsi","year":"2018","journal-title":"Respir. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1189\/jlb.0512231","article-title":"The mannose receptor","volume":"92","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41564-018-0280-x","article-title":"Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival","volume":"4","author":"Subramanian","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/imm.13546","article-title":"Pneumolysin suppresses the initial macrophage pro-inflammatory response to Streptococcus pneumoniae","volume":"167","author":"Periselneris","year":"2022","journal-title":"Immunology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"33561","DOI":"10.1073\/pnas.2015368117","article-title":"Macrophage LC3-associated phagocytosis is an immune defense against Streptococcus pneumoniae that diminishes with host aging","volume":"117","author":"Inomata","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/bs.mcb.2021.02.003","article-title":"Measuring oxidation within LC3-associated phagosomes that optimizes MHC class II restricted antigen presentation","volume":"164","author":"Ligeon","year":"2021","journal-title":"Methods Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"573266","DOI":"10.3389\/fimmu.2021.573266","article-title":"Pneumolysin is responsible for differential gene expression and modifications in the epigenetic landscape of primary monocyte derived macrophages","volume":"12","author":"Cole","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1159\/000522339","article-title":"Streptococcus pneumoniae impairs maturation of human dendritic cells and consequent activation of CD4+ T cells via pneumolysin","volume":"14","author":"Paulikat","year":"2022","journal-title":"J. Innate Immun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1128\/JB.01489-08","article-title":"Pneumolysin localizes to the cell wall of Streptococcus pneumoniae","volume":"191","author":"Price","year":"2009","journal-title":"J. Bacteriol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1128\/JB.00114-12","article-title":"Export requirements of pneumolysin in Streptococcus pneumoniae","volume":"194","author":"Price","year":"2012","journal-title":"J. Bacteriol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1128\/IAI.70.6.2886-2890.2002","article-title":"Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type","volume":"70","author":"Kadioglu","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12974-018-1235-0","article-title":"Necroptosis: A regulated inflammatory mode of cell death","volume":"15","author":"Dhuriya","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3389\/fimmu.2019.00615","article-title":"Necroptotic cell death promotes adaptive immunity against colonizing pneumococci","volume":"10","author":"Riegler","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3389\/fmicb.2020.01543","article-title":"Pneumolysin: Pathogenesis and therapeutic target","volume":"11","author":"Nishimoto","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1097\/01.CCM.0000220496.48295.A9","article-title":"Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia","volume":"34","author":"Witzenrath","year":"2006","journal-title":"Crit. Care Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1172\/JCI117631","article-title":"Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia","volume":"95","author":"Rubins","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/cdd.2017.49","article-title":"Pore-forming toxin-mediated ion dysregulation leads to death receptor-independent necroptosis of lung epithelial cells during bacterial pneumonia","volume":"24","author":"Bradley","year":"2017","journal-title":"Cell Death Differ."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1086\/318536","article-title":"Proinflammatory interactions of pneumolysin with human neutrophils","volume":"183","author":"Cockeran","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1097\/01.CCM.0000269212.84709.23","article-title":"Role of platelet-activating factor in pneumolysin-induced acute lung injury","volume":"35","author":"Witzenrath","year":"2007","journal-title":"Crit. Care Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ajpath.2019.11.004","article-title":"Endothelial cell calcium signaling during barrier function and inflammation","volume":"190","author":"Dalal","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1164\/rccm.201708-1733OC","article-title":"Prognostic and pathogenic role of angiopoietin-1 and -2 in pneumonia","volume":"198","author":"Gutbier","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"a006550","DOI":"10.1101\/cshperspect.a006650","article-title":"The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway","volume":"2","author":"Thurston","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature21706","article-title":"The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors","volume":"544","author":"Caudrillier","year":"2017","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1152\/physiol.00017.2019","article-title":"Platelet biogenesis in the lung circulation","volume":"34","author":"Looney","year":"2019","journal-title":"Physiology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00408-016-9900-5","article-title":"Pneumolysin mediates platelet activation in vitro","volume":"194","author":"Nel","year":"2016","journal-title":"Lung"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Letsiou, E., Teixeira Alves, L.G., Felten, M., Mitchell, T.J., M\u00fcller-Redetzky, H.C., Dudek, S.M., and Witzenrath, M. (2021). Neutrophil-derived extracellular vesicles activate platelets after pneumolysin exposure. Cells, 10.","DOI":"10.3390\/cells10123581"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-0463.2011.02813.x","article-title":"Characterization of recombinant Streptococcus mitis-derived human platelet aggregation factor","volume":"120","author":"Ohkuni","year":"2012","journal-title":"APMIS"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1182\/bloodadvances.2020002372","article-title":"Pneumolysin induces platelet destruction, not platelet activation, which can be prevented by immunoglobulin preparations in vitro","volume":"4","author":"Jahn","year":"2020","journal-title":"Blood Adv."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jinf.2017.02.010","article-title":"Pneumolysin mediates heterotypic aggregation of neutrophils and platelets in vitro","volume":"74","author":"Nel","year":"2017","journal-title":"J. Infect."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/cei.12766","article-title":"Pneumolysin activates neutrophil extracellular trap formation","volume":"184","author":"Nel","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2016-09-741298","article-title":"Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice","volume":"129","author":"McDonald","year":"2017","journal-title":"Blood"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fcvm.2019.00085","article-title":"Platelet-neutrophil interplay: Insights into neutrophil extracellular trap (NET)-driven coagulation in infection","volume":"6","author":"Zucoloto","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e20201012","DOI":"10.1084\/jem.20201012","article-title":"Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19","volume":"217","author":"Radermecker","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"102925","DOI":"10.1016\/j.ebiom.2020.102925","article-title":"Vascular occlusion by neutrophil extracellular traps in COVID-19","volume":"58","author":"Leppkes","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"19327","DOI":"10.18632\/oncotarget.8451","article-title":"Capsules of virulent pneumococcal serotypes enhance formation of neutrophil extracellular traps during in vivo pathogenesis of pneumonia","volume":"7","author":"Moorthy","year":"2016","journal-title":"Oncotarget"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.bbamcr.2014.09.005","article-title":"Ca2-dependent repair of pneumolysin pores: A new paradigm for host cellular defense against bacterial pore-forming toxins","volume":"1853","author":"Wolfmeier","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1096\/fj.201901737RR","article-title":"Bacterial pore-forming toxin pneumolysin: Cell membrane structure and microvesicle shedding capacity determines differential survival of cell types","volume":"34","author":"Larpin","year":"2020","journal-title":"FASEB J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1093\/infdis\/jiaa639","article-title":"Reversion of pneumolysin-induced executioner caspase activation redirects cells to survival","volume":"223","author":"Nerlich","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"945656","DOI":"10.3389\/fimmu.2022.945656","article-title":"Protective role of Cav-1 in pneumolysin-induced endothelial barrier dysfunction","volume":"13","author":"Batori","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_65","first-page":"e201602000024","article-title":"Staphylococcus aureus alpha toxin can bind to cholesterol-senswitive phosphatidyl choline head group arrangements","volume":"2","author":"Thurnheer","year":"2016","journal-title":"Matters"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/01.CIR.101.1.78","article-title":"Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts: Role of thromboxane generation","volume":"101","author":"Sibelius","year":"2000","journal-title":"Circulation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/cid\/ciad065","article-title":"The risk of acute myocardial infarction among patients with laboratory-confirmed invasive pneumococcal disease: A self-controlled case series study","volume":"76","author":"Wiese","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Brown, A.O., Mann, B., Gao, G., Hankins, J.S., Humann, J., Giardina, J., Faverio, P., Restrepo, M.I., Halade, G.V., and Mortensen, E.M. (2014). Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004383"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1164\/rccm.201411-1951PP","article-title":"Cardiotoxicity during invasive pneumococcal disease","volume":"191","author":"Brown","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1164\/rccm.201701-0104OC","article-title":"Severe pneumococcal pneumonia causes acute cardiac toxicity and subsequent cardiac remodeling","volume":"196","author":"Reyes","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Shenoy, A.T., Beno, S.M., Brissac, T., Bell, J.W., Novak, L., and Orihuela, C.J. (2018). Severity and properties of cardiac damage caused by Streptococcus pneumoniae are strain dependent. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0204032"},{"key":"ref_72","first-page":"000784","article-title":"Targeted control of pneumolysin production by a mobile genetic element in Streptococcus pneumoniae","volume":"8","author":"Stevens","year":"2022","journal-title":"Microb. Genom."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1128\/IAI.00007-16","article-title":"Infiltrated macrophages die of pneumolysin-mediated necroptosis following pneumococcal myocardial invasion","volume":"84","author":"Gilley","year":"2016","journal-title":"Infect. Immun."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Shenoy, A.T., Brissac, T., Gilley, R.P., Kumar, N., Wang, Y., Gonzalez-Juarbe, N., Hinkle, W.S., Daugherty, S.C., Shetty, A.C., and Ott, S. (2017). Streptococcus pneumoniae in the heart subvert the host response through biofilm-mediated resident macrophage killing. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006582"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/infdis\/jiaa295","article-title":"Inhibition of necroptosis to prevent long-term cardiac damage during pneumococcal pneumonia and invasive disease","volume":"222","author":"Beno","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e0325721","DOI":"10.1128\/mbio.03257-21","article-title":"Pandemic influenza infection promotes Streptococcus pneumoniae Infiltration, necrotic damage, and proteomic remodeling in the heart","volume":"13","author":"Platt","year":"2022","journal-title":"MBio"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"102535","DOI":"10.1016\/j.isci.2021.102535","article-title":"Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles","volume":"24","author":"Syed","year":"2021","journal-title":"IScience"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/cid\/ciac317","article-title":"The effect of macrolides on mortality in bacteremic pneumococcal pneumonia: A retrospective, Nationwide Cohort Study, Israel, 2009\u20132017","volume":"75","author":"Chowers","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"ofab063","DOI":"10.1093\/ofid\/ofab063","article-title":"A multicenter evaluation of the US prevalence and regional variation in macrolide-resistant S. pneumoniae in ambulatory and hospitalized adult patients in the United States","volume":"8","author":"Gupta","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1164\/rccm.201504-0701ED","article-title":"Macrolide-resistant pneumococcus in community-acquired pneumonia. Is there still a role for macrolide therapy?","volume":"191","author":"Niederman","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/resp.13248","article-title":"Empiric antibiotics for community-acquired pneumonia: A macrolide and a beta-lactam please!","volume":"23","author":"Waterer","year":"2018","journal-title":"Respirology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1164\/rccm.201502-0212OC","article-title":"The effect of macrolide resistance on the presentation and outcome of patients hospitalized for Streptococcus pneumoniae pneumonia","volume":"191","author":"Cilloniz","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pharmrev.121.000300","article-title":"Nonantimicrobial actions of macrolides: Overview and perspectives for future development","volume":"73","author":"Kricker","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/M20-2189","article-title":"Treatment of community-acquired pneumonia during the coronavirus disease 2019 (COVID-19) pandemic","volume":"173","author":"Metlay","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s40121-021-00471-1","article-title":"The role of macrolides for the management of community-acquired pneumonia and pneumonia by the novel coronavirus SARS-CoV-2 (COVID-19): A position paper by four medical societies from Greece","volume":"10","author":"Daikos","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fphar.2019.00489","article-title":"Respiratory fluoroquinolones monotherapy vs. \u03b2-lactams with or without macrolides for hospitalized community-acquired pneumonia patients: A meta-analysis","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jgar.2022.05.009","article-title":"Empirical antibiotic treatment strategies for community-acquired pneumonia: A network meta-analysis","volume":"30","author":"Xu","year":"2022","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1097\/MJT.0000000000000788","article-title":"Effect of \u03b2-lactam plus macrolide versus fluoroquinolone on 30-day readmissions for community-acquired pneumonia","volume":"27","author":"Gillbert","year":"2020","journal-title":"Am. J. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.3346\/jkms.2022.37.e324","article-title":"Beta-lactam plus macrolide for patients hospitalized with community-acquired pneumonia: Difference between autumn and spring","volume":"37","author":"Kim","year":"2022","journal-title":"J. Korean Med. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1900824","DOI":"10.1183\/13993003.00824-2019","article-title":"Macrolide combination therapy for patients hospitalised with community-acquired pneumonia? An individualised approach supported by machine learning","volume":"54","author":"Cao","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.ajem.2018.01.079","article-title":"Ceftriaxone combination therapy versus respiratory fluoroquinolone monotherapy for community-acquired pneumonia: A meta-analysis","volume":"36","author":"Zhang","year":"2018","journal-title":"Am. J. Emerg. Med."},{"key":"ref_93","first-page":"6","article-title":"Beta-lactam plus a macrolide versus a fluoroquinolone for empiric therapy of hospitalized patients with community-acquired pneumonia: Results from the University of Louisville Pneumonia Study","volume":"3","author":"Salunkhe","year":"2019","journal-title":"Univ. Louisville J. Respir. Infect."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41479-021-00093-8","article-title":"Additional effect of azithromycin over \u03b2-lactam alone for severe community-acquired pneumonia-associated acute respiratory distress syndrome: A retrospective cohort study","volume":"14","author":"Suzuki","year":"2022","journal-title":"Pneumonia"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.chest.2018.11.006","article-title":"Effect of combined \u03b2-lactam\/macrolide therapy on mortality according to the microbial etiology and inflammatory status of patients with community-acquired pneumonia","volume":"155","author":"Ceccato","year":"2019","journal-title":"Chest"},{"key":"ref_96","first-page":"253","article-title":"The benefit of macrolide therapy in patients with pneumococcal pneumonia is only present in patients with bacteremia","volume":"29","author":"Costa","year":"2022","journal-title":"Pulmonology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"18406","DOI":"10.1038\/s41598-019-54922-4","article-title":"Azithromycin combination therapy for community-acquired pneumonia: Propensity score analysis","volume":"9","author":"Ito","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.clinthera.2019.10.005","article-title":"Outcomes of macrolide de-escalation in severe community-acquired pneumonia","volume":"41","author":"Hopkins","year":"2019","journal-title":"Clin. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11908-018-0651-8","article-title":"Moving past the routine use of macrolides\u2014Reviewing the role of combination therapy in community-acquired pneumonia","volume":"20","author":"Shumilak","year":"2018","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_100","first-page":"2439","article-title":"Meta-analysis of the effects of combination therapies of \u03b2-lactams and fluoroquinolones or macrolides in the treatment of community-acquired pneumonia","volume":"13","author":"Li","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3346\/jkms.2017.32.1.77","article-title":"Is \u03b2-lactam plus macrolide more effective than \u03b2-lactam plus fluoroquinolone among patients with severe community-acquired pneumonia? A systemic review and meta-analysis","volume":"32","author":"Lee","year":"2017","journal-title":"J. Korean Med. Sci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-9255-8-17","article-title":"In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin","volume":"8","author":"Tsoupras","year":"2011","journal-title":"J. Inflamm."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e01556-18","DOI":"10.1128\/AAC.01556-18","article-title":"A hypothesis-generating study of the combination of aspirin plus macrolides in patients with severe community-acquired pneumonia","volume":"63","author":"Falcone","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jiac.2022.04.020","article-title":"Efficacy of erythromycin compared to clarithromycin and azithromycin in adults or adolescents with community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Ashy","year":"2022","journal-title":"J. Infect. Chemother."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3000605211049943","DOI":"10.1177\/03000605211049943","article-title":"Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: A systematic review","volume":"49","author":"Gillani","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"ref_106","first-page":"100931","article-title":"Efficacy of empiric macrolides versus fluoroquinolones in community-acquired pneumonia associated with atypical bacteria: A meta-analysis","volume":"82","author":"Basilim","year":"2022","journal-title":"Respir. Med. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"106307","DOI":"10.1016\/j.rmed.2021.106307","article-title":"Pneumococcal community-acquired pneumonia in the intensive care unit: Azithromycin remains protective despite macrolide resistance","volume":"177","author":"Shorr","year":"2021","journal-title":"Respir. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/23744235.2017.1350881","article-title":"The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: Results from the Community-Acquired Pneumonia Organization","volume":"50","author":"Peyrani","year":"2018","journal-title":"Infect. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Cima Cabal, M.D., Molina, F., L\u00f3pez-S\u00e1nchez, J.I., P\u00e9rez-Sant\u00edn, E., and Del Mar Garc\u00eda-Su\u00e1rez, M. (2023). Pneumolysin as a target for new therapies against pneumococcal infections: A systematic review. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0282970"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1473-3099(18)30805-3","article-title":"CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: A first-in-human, double-blind, placebo-controlled, randomised trial","volume":"19","author":"Laterre","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41479-022-00097-y","article-title":"The remarkable history of pneumococcal vaccination: An ongoing challenge","volume":"14","author":"Musher","year":"2022","journal-title":"Pneumonia"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e12695","DOI":"10.15252\/emmm.202012695","article-title":"Mannose receptor-derived peptides neutralize pore-forming toxins and reduce inflammation and development of pneumococcal disease","volume":"12","author":"Subramanian","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jac\/46.5.717","article-title":"Subinhibitory concentrations of erythromycin reduce pneumococcal adherence to respiratory epithelial cells in vitro","volume":"46","author":"Lagrou","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1183\/09031936.06.00116805","article-title":"Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae","volume":"27","author":"Fukuda","year":"2006","journal-title":"Eur. Respir. J."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/jac\/dkl479","article-title":"Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae","volume":"59","author":"Anderson","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/jac\/dkm338","article-title":"Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro","volume":"60","author":"Anderson","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.idc.2004.04.010","article-title":"Macrolides and ketolides: Azithromycin, clarithromycin, telithromycin","volume":"18","author":"Zuckerman","year":"2004","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_118","first-page":"1","article-title":"Effects of clarithromycin at sub-minimum inhibitory concentrations on early ermB gene expression, metabolic activity and growth of an erm(B)-expressing macrolide-resistant strain of Streptococcus pneumoniae","volume":"2","author":"Cockeran","year":"2012","journal-title":"Open J. Respir. Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e00161-18","DOI":"10.1128\/AAC.00161-18","article-title":"Mechanism of macrolide-induced inhibition of pneumolysin release involves impairment of autolysin release in macrolide-resistant Streptococcus pneumoniae","volume":"62","author":"Domon","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e0031821","DOI":"10.1128\/Spectrum.00318-21","article-title":"Clarithromycin inhibits pneumolysin production via downregulation of ply gene transcription despite autolysis activation","volume":"9","author":"Domon","year":"2021","journal-title":"Microbiol. Spectr."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/13\/11038\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:05:29Z","timestamp":1760126729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/13\/11038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":120,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["ijms241311038"],"URL":"https:\/\/doi.org\/10.3390\/ijms241311038","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]}}}